- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01966380
Proof of Concept (Design Validation) in Patient With Hard to Heal Wounds Such as Pressure Ulcer, Diabetic Foot Ulcer and Leg Ulcer, Leia
December 22, 2015 updated by: Molnlycke Health Care AB
An Open Randomised, Prospective, Crossover, Proof of Concept (Design Validation) Clinical Investigation to Caompare the Performance and Safety of Wound Dressing(Leia) Compared to and Hydroactive Surgical Dressing on Low to Highly Exuding Wounds
The purpose of this reseach study is to determine Mölnlycke Health Care´s Leia dressing performance properties is fulfilled and that the dressing is safe when used on wound types such as pressure ulcer, leg ulcer, and diabetic foot ulcer.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
6
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Göteborg, Sweden, 41346
- Sahlgrenska clinical trial center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Low to highly exuding chronic wound(wound history > 2 months) such as Leg Ulcer, Pressure Ulcer Category III to IV or Diabetic Foot Ulcer
- Male of female, 18 years and above
- Signed Informed Consent Form
Exclusion Criteria:
- Pregnancy or lactation
- Wound size not suitable for the wound dressing size
- Known allergy/hypersensitivity to any of the components in the dressing
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Device, dressing
Intervention: Device, Leia dressing
|
Other Names:
|
Active Comparator: Dressing , device
Intervention: Device: Hydroactive surgical dressing
|
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Absorption of Wound Exudates.
Time Frame: 2-3 weeks
|
Absorption capacity measured subjectively: NA/POOR/GOOD/VERY GOOD/EXCELLENT
|
2-3 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2013
Primary Completion (Actual)
February 1, 2014
Study Completion (Actual)
March 1, 2014
Study Registration Dates
First Submitted
October 9, 2013
First Submitted That Met QC Criteria
October 16, 2013
First Posted (Estimate)
October 21, 2013
Study Record Updates
Last Update Posted (Estimate)
December 23, 2015
Last Update Submitted That Met QC Criteria
December 22, 2015
Last Verified
December 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Leia
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Leg Ulcer
-
Nantes University HospitalCompletedHypertensive Leg UlcerFrance
-
University Hospital, Strasbourg, FranceTerminated
-
Assistance Publique - Hôpitaux de ParisCompletedMARTORELL'S ULCER | Hypertensive Leg Ulcer | Necrotic AngiodermatitisFrance
-
Pharma 2100WithdrawnArterial Leg UlcerDenmark
-
SoftOx Solutions ASCompletedVenous Leg Ulcer | Chronic Leg UlcerDenmark
-
Piomic Medical AGVenenklinik Bellevue; Kantonsspital Nidwalden; Spital MännedorfCompletedLeg Ulcers Venous | Leg Ulcer Arterial | Leg Ulcer MixedSwitzerland
-
SolasCure LimitedCompletedVenous Leg Ulcer | Leg Injuries and DisordersUnited States, Hungary, United Kingdom
-
Ahram Canadian UniversityRecruiting
-
Firstkind LtdTerminatedLeg Ulcer | Venous Leg Ulcer | Venous UlcerCanada
-
Central Hospital, Nancy, FranceUnknownArteritic Leg Ulcer